Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis.
Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered.
Reviewing the role of Resveratrol as a natural modulator of microglial activities.
Update in vitamin D and multiple sclerosis.
The number of optic neuritis attacks is a potential confounder when comparing patients with NMO vs. controls by voxel-based neuroimaging analysis.
Targeting intrinsically disordered proteins in rational drug discovery.
Evidence of extensive RNA oxidation in normal appearing cortex of multiple sclerosis brain.
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.
The role of Ets2 transcription factor in the induction of microRNA-155 by LPS, and its targeting by IL-10.
Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation.
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
The Olig family affects central nervous system development and disease.
Recognising and diagnosing inflammatory brain disease.
Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.
Efferent manifestations of multiple sclerosis.
Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease.
A novel model of demyelination and remyelination in a GFP-transgenic zebrafish.
Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
What place for {blacktriangledown}cannabis extract in MS?
Pages
« first
‹ previous
…
414
415
416
417
418
419
420
421
422
…
next ›
last »